1. Medtech Insight
  2. >>Geography
  3. >>Europe

European Commission Extends Time IVD Companies Can Use Lead In PVC Sensors

 
• By Amanda Maxwell

No adequate substitution of lead in specific sensors means that some IVDs will remain exempt  for now from the EU Directive on the Restriction of Hazardous Substances in Electrical and Electronic Equipment (RoHS)

Deadline Extended
• Source: Shutterstock

Manufacturers of IVD products have a short reprieve – until the end of the year − when it comes to using lead as a thermal stabilizer in polyvinyl chloride (PVC) sensors.

The decision has been made by the European Commission in the context of the Restriction of Hazardous Substances in Electrical and Electronic Equipment (RoHS) Directive because there has

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

More from Geography